Caplin Point commences commercial production from its injectables plant Illustrative image – not actual.

Caplin Point Laboratories has commenced commercial production from its state-of-the-art injectables plant located at Guruvarajakandigai village, Gummidipoondi, in Tiruvallur district of Tamil Nadu.

 

The injectables plant has a total capacity of 200 lakh pieces per year.

 

The company has now begun the process of submitting the required documents for obtaining approval from the regulatory bodies such as UKMHRA, ANVISA, BRAZIL, USFDA, and EUGMP which will enable export of injectables in various dosage forms to the regulated markets.

 

With the start of functioning of this facility, Caplin Point will be in a position to offer contract manufacturing services in the areas of general category injectable dosage forms, specialized category injectable dosage forms (such as hormones and anabolic steroids) and semi-solid dosages such as ointments and suppositories, from dedicated units.

 

Related Link:
Project profile

← All latest storiesBack to top →